These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

935 related items for PubMed ID: 17050922

  • 1. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
    Barraud N, Hassett DJ, Hwang SH, Rice SA, Kjelleberg S, Webb JS.
    J Bacteriol; 2006 Nov; 188(21):7344-53. PubMed ID: 17050922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterizations of the viability and gene expression of dispersal cells from Pseudomonas aeruginosa biofilms released by alginate lyase and tobramycin.
    Daboor SM, Raudonis R, Cheng Z.
    PLoS One; 2021 Nov; 16(10):e0258950. PubMed ID: 34695148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Furoxan Nitric Oxide Donors Disperse Pseudomonas aeruginosa Biofilms, Accelerate Growth, and Repress Pyoverdine Production.
    Poh WH, Barraud N, Guglielmo S, Lazzarato L, Rolando B, Fruttero R, Rice SA.
    ACS Chem Biol; 2017 Aug 18; 12(8):2097-2106. PubMed ID: 28628310
    [Abstract] [Full Text] [Related]

  • 7. In Vitro Evaluation of Biofilm Dispersal as a Therapeutic Strategy To Restore Antimicrobial Efficacy.
    Roizman D, Vidaillac C, Givskov M, Yang L.
    Antimicrob Agents Chemother; 2017 Oct 18; 61(10):. PubMed ID: 28760898
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.
    Reighard KP, Schoenfisch MH.
    Antimicrob Agents Chemother; 2015 Oct 18; 59(10):6506-13. PubMed ID: 26239983
    [Abstract] [Full Text] [Related]

  • 9. Nitric Oxide and Iron Signaling Cues Have Opposing Effects on Biofilm Development in Pseudomonas aeruginosa.
    Zhu X, Rice SA, Barraud N.
    Appl Environ Microbiol; 2019 Feb 01; 85(3):. PubMed ID: 30478229
    [Abstract] [Full Text] [Related]

  • 10. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN, Webb JS.
    Mol Ther; 2017 Sep 06; 25(9):2104-2116. PubMed ID: 28750737
    [Abstract] [Full Text] [Related]

  • 11. A Microfluidic Approach to Investigating a Synergistic Effect of Tobramycin and Sodium Dodecyl Sulfate on Pseudomonas aeruginosa Biofilms.
    Shin S, Ahmed I, Hwang J, Seo Y, Lee E, Choi J, Moon S, Hong JW.
    Anal Sci; 2016 Sep 06; 32(1):67-73. PubMed ID: 26753708
    [Abstract] [Full Text] [Related]

  • 12. Analysis of Pseudomonas aeruginosa PAO1 Biofilm Protein Profile After Exposure to n-Butanolic Cyclamen coum Extract Alone and in Combination with Ciprofloxacin.
    Shafiei M, Abdi-Ali A, Shahcheraghi F, Vali H, Shahbani Zahiri H, Akbari Noghabi K.
    Appl Biochem Biotechnol; 2017 Aug 06; 182(4):1444-1457. PubMed ID: 28138928
    [Abstract] [Full Text] [Related]

  • 13. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA.
    Antimicrob Agents Chemother; 2007 May 06; 51(5):1813-7. PubMed ID: 17353241
    [Abstract] [Full Text] [Related]

  • 14. Optimal dosing regimen of nitric oxide donor compounds for the reduction of Pseudomonas aeruginosa biofilm and isolates from wastewater membranes.
    Barnes RJ, Bandi RR, Wong WS, Barraud N, McDougald D, Fane A, Kjelleberg S, Rice SA.
    Biofouling; 2013 May 06; 29(2):203-12. PubMed ID: 23368407
    [Abstract] [Full Text] [Related]

  • 15. Origin and Impact of Nitric Oxide in Pseudomonas aeruginosa Biofilms.
    Cutruzzolà F, Frankenberg-Dinkel N.
    J Bacteriol; 2016 Jan 01; 198(1):55-65. PubMed ID: 26260455
    [Abstract] [Full Text] [Related]

  • 16. Biofilm dispersion in Pseudomonas aeruginosa.
    Kim SK, Lee JH.
    J Microbiol; 2016 Feb 01; 54(2):71-85. PubMed ID: 26832663
    [Abstract] [Full Text] [Related]

  • 17. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    Soren O, Rineh A, Silva DG, Cai Y, Howlin RP, Allan RN, Feelisch M, Davies JC, Connett GJ, Faust SN, Kelso MJ, Webb JS.
    J Antimicrob Chemother; 2020 Jan 01; 75(1):117-125. PubMed ID: 31682251
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2008 Apr 01; 31(4):329-36. PubMed ID: 18280117
    [Abstract] [Full Text] [Related]

  • 19. Optimization of nitric oxide donors for investigating biofilm dispersal response in Pseudomonas aeruginosa clinical isolates.
    Cai YM, Webb JS.
    Appl Microbiol Biotechnol; 2020 Oct 01; 104(20):8859-8869. PubMed ID: 32865612
    [Abstract] [Full Text] [Related]

  • 20. Loss of the Two-Component System TctD-TctE in Pseudomonas aeruginosa Affects Biofilm Formation and Aminoglycoside Susceptibility in Response to Citric Acid.
    Taylor PK, Zhang L, Mah TF.
    mSphere; 2019 Mar 06; 4(2):. PubMed ID: 30842268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.